NCT05053269

Brief Summary

Bronchopulmonary dysplasia (BPD) is one of the most common, complex, and severe diseases in preterm infants. BPD was first described as chronic pulmonary disease in survivors of severe respiratory distress syndrome (RDS) in 1967, which was also called as the "old" BPD. In recent years, the definition for BPD has developed a lot. The National Institute of Child Health and Human Development (NICHD) workshop in 2018 assessed BPD at 36 post-menstrual age (PMA) along with radiographic confirmation and used a severity grading of I-III. Although with effective surfactant supplement and oxygen support, BPD brings a great challenge to neonatologists.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 22, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 1, 2023

Status Verified

October 1, 2022

Enrollment Period

3.3 years

First QC Date

September 12, 2021

Last Update Submit

April 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • the incidence of BPD

    the infant was diagnosed with BPD

    up to 36 weeks' gestational age

Secondary Outcomes (1)

  • body weight growth after birth

    up to 36 weeks' gestational age

Study Arms (2)

good body weight growth

body weight growth after birth is consistent with the growth curve

Other: good body weight growth

poor body weight growth

body weight growth after birth is inconsistent with the growth curve

Other: poor body weight growth

Interventions

body weight growth after birth is consistent with the growth curve

good body weight growth

body weight growth after birth is inconsistent with the growth curve

poor body weight growth

Eligibility Criteria

Age1 Minute - 1 Day
Sexall
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

the preterm infants' gestational age is equal to or less than 32 weeks will be included in the study

You may qualify if:

  • equal to or less than 32 weeks' gestational age

You may not qualify if:

  • main congenital malformation
  • parents' refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400042, China

Location

MeSH Terms

Conditions

Bronchopulmonary DysplasiaPremature Birth

Condition Hierarchy (Ancestors)

Ventilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

September 12, 2021

First Posted

September 22, 2021

Study Start

October 1, 2021

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

May 1, 2023

Record last verified: 2022-10

Locations